✦ LIBER ✦

Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation

✍ Scribed by Clemens Aigner; Peter Jaksch; Guenther Winkler; Kriztina Czebe; Shahrokh Taghavi; Gabriel Marta; Walter Klepetko

Book ID: 106171847
Publisher: Springer Vienna
Year: 2005
Tongue: English
Weight: 68 KB
Volume: 117
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-005-0413-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral valganciclovir as pre-emptive thera

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients

✍ van der Heiden, P L J; Kalpoe, J S; Barge, R M; Willemze, R; Kroes, A C M; Schip 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Extended routine polymerase chain reacti

Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

✍ Karl S. Peggs; Wolfgang Preiser; Panagiotis D. Kottaridis; Nikki McKeag; Nicola 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Cytomegalovirus pp65 antigenemia-guided

Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience

✍ Manteiga, R; Martino, R; Sureda, A; Labeaga, R; Brunet, S; Sierra, J; Rabella, N 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB

Pre-emptive therapy against cytomegalovi

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

✍ Kanda, Y; Mineishi, S; Saito, T; Seo, S; Saito, A; Suenaga, K; Ohnishi, M; Niiya 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Pre-emptive therapy with rituximab for p

Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation

✍ Gruhn, B; Meerbach, A; Häfer, R; Zell, R; Wutzler, P; Zintl, F 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Results of a phase I/II British Society

Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation

✍ Z.Y. Lim; G. Cook; P.R. Johnson; Anne Parker; M. Zuckerman; D. Marks; H. Wiltshi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 218 KB

This multi-centre randomized study assessed the bioavailability of ganciclovir in patients undergoing alemtuzumab-based reduced intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT) after oral administration of valganciclovir. Patients were randomized to 2 groups receiving eit